Similares a SGLT2 Inhibitors May Reduce COPD Readmissions I ATS 2026

20 vecinos (text_768) · 48 views · HCPLive · Estados Unidos


★	SGLT2 Inhibitors May Reduce COPD Readmissions I ATS 2026	HCPLive @hcplivenews	48	Estados Unidos
17	Mepolizumab Add-On Reduces COPD Exacerbations in Triple-Therapy Patients \| ATS 2026	HCPLive @hcplivenews	1.2K	Estados Unidos	87
20	Diabetes Dialogue: FDA Approves Afrezza Inhaled Insulin for Pediatric Patients	HCPLive @hcplivenews	683	Estados Unidos	86
10	Diabetes Dialogue: The ADA’s Statement on Diabetes Tech Integration, With Eugene Wright Jr., MD	HCPLive @hcplivenews	584	Estados Unidos	87
12	Sotatercept May Improve Right Heart Function in #pulmonaryhypertension	HCPLive @hcplivenews	232	Estados Unidos	87
13	Diabetes Dialogue: Tech, Screening, and Care Highlights from ADCES 2026	HCPLive @hcplivenews	224	Estados Unidos	87
4	Mixed AERIFY Data May Delay Itepekimab Approval Pathway in COPD, With Klaus F. Rabe, MD, PhD	HCPLive @hcplivenews	198	Estados Unidos	88
9	Diabetes Dialogue: CKM Systems, Triple Agonists, and a Sensor Scandal Ahead of ADA	HCPLive @hcplivenews	179	Estados Unidos	87
2	Rapid Evolution in GLP-1s and Therapeutics at ADA 2026	HCPLive @hcplivenews	171	Estados Unidos	88
11	Diabetes Dialogue: CONNECT, TRANSCEND, and TRIUMPH at ADA 2026	HCPLive @hcplivenews	114	Estados Unidos	87
19	Mepolizumab Reduced COPD Hospitalizations in Eosinophilic Disease \| ATS 2026 With Gerard Criner, MD	HCPLive @hcplivenews	113	Estados Unidos	87
14	Sotatercept May Improve RV Function in Group 3 3 Pulmonary Hypertension	HCPLive @hcplivenews	112	Estados Unidos	87
1	AERIFY: Phase 3 Data Reveal Challenges, Potential of Itepekimab in COPD	HCPLive @hcplivenews	105	Estados Unidos	88
18	Diabetes Dialogue: Diabetes Technology and Treatment in the UK, With Ketan Dhatariya, MD, PhD, MS	HCPLive @hcplivenews	94	Estados Unidos	87
8	Diabetes Dialogue: The International Diabetes Federation and Care in India, With Amit Gupta, MBBS	HCPLive @hcplivenews	79	Estados Unidos	87
7	Incretins, Monitors, and Insulin Titration at ADA 2026	HCPLive @hcplivenews	76	Estados Unidos	87
16	ATS 2026 Pulmonology: AD109, Ralinepag, ALIS, Itepekimab & More \| HCPLive Expert Interviews	HCPLive @hcplivenews	55	Estados Unidos	87
5	Diabetes Dialogue: Teplizumab, Stelo, and Inhaled Insulin Afrezza for Pediatric Patients	HCPLive @hcplivenews	53	Estados Unidos	88
6	Continuous Ketone Monitoring May Guide SGLT2i Use in T1D	HCPLive @hcplivenews	33	Estados Unidos	88
3	Pegtarazimod Cuts Oxygen Need in Hospitalized COPD Patients \| ATS 2026 \| Gerald Criner, MD	HCPLive @hcplivenews	29	Estados Unidos	88
15	Does Insulin Resistance Harm the Lungs? CT Data Offers New Clues \| ATS 2026	HCPLive @hcplivenews	25	Estados Unidos	87